These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15924335

  • 1. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity.
    Hatziapostolou M, Delbe J, Katsoris P, Polytarchou C, Courty J, Papadimitriou E.
    Prostate; 2005 Oct 01; 65(2):151-8. PubMed ID: 15924335
    [Abstract] [Full Text] [Related]

  • 2. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A, Lampropoulou E, Mikelis C, Drosou G, Papadimitriou E.
    Eur J Cell Biol; 2008 Jan 01; 87(1):17-29. PubMed ID: 17881084
    [Abstract] [Full Text] [Related]

  • 3. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
    Papadimitriou E, Polykratis A, Courty J, Koolwijk P, Heroult M, Katsoris P.
    Biochem Biophys Res Commun; 2001 Mar 23; 282(1):306-13. PubMed ID: 11264008
    [Abstract] [Full Text] [Related]

  • 4. Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells.
    Kokolakis G, Mikelis C, Papadimitriou E, Courty J, Karetsou E, Katsoris P.
    In Vivo; 2006 Mar 23; 20(5):629-35. PubMed ID: 17091770
    [Abstract] [Full Text] [Related]

  • 5. [Implication of HARP in angiogenesis and possible therapeutic role].
    Delbe J, Katsoris P, Milhiet PE, Barritault D, Caruelle D, Courty J.
    Pathol Biol (Paris); 1999 Apr 23; 47(4):352-7. PubMed ID: 10372404
    [Abstract] [Full Text] [Related]

  • 6. A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.
    Bermek O, Diamantopoulou Z, Polykratis A, Dos Santos C, Hamma-Kourbali Y, Burlina F, Delbé J, Chassaing G, Fernig DG, Katsoris P, Courty J.
    Exp Cell Res; 2007 Nov 15; 313(19):4041-50. PubMed ID: 17727841
    [Abstract] [Full Text] [Related]

  • 7. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
    Polykratis A, Delbé J, Courty J, Papadimitriou E, Katsoris P.
    Int J Biochem Cell Biol; 2004 Oct 15; 36(10):1954-66. PubMed ID: 15203110
    [Abstract] [Full Text] [Related]

  • 8. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
    Delbé J, Vacherot F, Laaroubi K, Barritault D, Courty J.
    J Cell Physiol; 1995 Jul 15; 164(1):47-54. PubMed ID: 7790396
    [Abstract] [Full Text] [Related]

  • 9. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z.
    Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958
    [Abstract] [Full Text] [Related]

  • 10. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene.
    Polytarchou C, Hatziapostolou M, Papadimitriou E.
    J Biol Chem; 2005 Dec 09; 280(49):40428-35. PubMed ID: 16199533
    [Abstract] [Full Text] [Related]

  • 11. Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells.
    Hatziapostolou M, Polytarchou C, Katsoris P, Courty J, Papadimitriou E.
    J Biol Chem; 2006 Oct 27; 281(43):32217-26. PubMed ID: 16940294
    [Abstract] [Full Text] [Related]

  • 12. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
    Achour A, Laaroubi D, Caruelle D, Barritault D, Courty J.
    Cell Mol Biol (Noisy-le-grand); 2001 Oct 27; 47 Online Pub():OL73-7. PubMed ID: 11936877
    [Abstract] [Full Text] [Related]

  • 13. Involvement of heparin affin regulatory peptide in human prostate cancer.
    Vacherot F, Caruelle D, Chopin D, Gil-Diez S, Barritault D, Caruelle JP, Courty J.
    Prostate; 1999 Feb 01; 38(2):126-36. PubMed ID: 9973098
    [Abstract] [Full Text] [Related]

  • 14. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A, Wernert N.
    Int J Mol Med; 2006 Nov 01; 18(5):941-50. PubMed ID: 17016625
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 16. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 18. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.
    Hamma-Kourbali Y, Bermek O, Bernard-Pierrot I, Karaky R, Martel-Renoir D, Frechault S, Courty J, Delbé J.
    BMC Cancer; 2011 May 30; 11():212. PubMed ID: 21624116
    [Abstract] [Full Text] [Related]

  • 19. [Effect of PC-1 gene expression on migration ability of prostate cancer cells].
    Zhang H, Wan LC, Wang J, Zhou JG, Huang CF.
    Ai Zheng; 2005 Sep 30; 24(9):1043-7. PubMed ID: 16159422
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.
    Bone; 2006 Feb 30; 38(2):154-66. PubMed ID: 16126463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.